K992399

Substantially Equivalent

ADDITIONAL IMS ASSAYS FOR THE BAYER ADVIA IMS SYSTEM

Applicant: Bayer Corp.
Product code: CIX
Advisory panel: Clinical Chemistry
Date received: 1999-07-19
Decision date: 1999-09-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.